C vs CSBR · P/E 16, rev $85.22B vs P/E 16, rev $56.9M
Citigroup Inc. (C) versus Champions Oncology Inc (CSBR) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
C currently screens at market cap $214.73B and trailing P/E 15.5. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Not investment advice. Open the C and CSBR stock pages for the full models.
Not investment advice.